About Lysine BioTech
Lysine BioTech is a company based in Thanjavur (India) founded in 2018 by Anandagopu Perumal. Lysine BioTech offers products and services including CAR T Cells, Gene Therapy, Biosimilars, Vaccines, and Metabolomic Informatics. Lysine BioTech operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Thanjavur, India
- Founders Anandagopu Perumal
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Lysine Biotech Private Limited
- Date of Incorporation 24 May, 2018
- Jurisdiction Chennai City Corporation, Tamil Nadu, India
-
Annual Revenue
$94.97 (USD)-98.61as on Mar 31, 2022
-
Net Profit
-$1.33 (USD)-107.55as on Mar 31, 2022
-
EBITDA
-$17.66 (USD)-2654.72as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lysine BioTech
Lysine BioTech offers a comprehensive portfolio of products and services, including CAR T Cells, Gene Therapy, Biosimilars, Vaccines, and Metabolomic Informatics.
Develops affordable CAR T cells for cancer and immune treatments.
Provides gene therapy solutions for various human diseases.
Creates cost-effective biosimilars as alternatives to original biologics.
Manufactures vaccines from proteins and DNA for disease prevention.
Analyzes natural products for antibiotics and industrial applications.
Funding Insights of Lysine BioTech
Detailed funding history for Lysine BioTech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lysine BioTech
Investment portfolio details for Lysine BioTech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lysine BioTech
Detailed financials for Lysine BioTech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lysine Biotech Comparisons
Peer comparison for Lysine BioTech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lysine BioTech
Lysine BioTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Detailed competitors of Lysine BioTech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lysine Biotech
Complete news archive for Lysine BioTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lysine BioTech
Lysine BioTech was founded in 2018.
Lysine BioTech is headquartered in Thanjavur, India. It is registered at Thanjavur, Tamil Nadu, India.
Annual revenue of Lysine BioTech is $94.97 as on Mar 31, 2022.
Lysine BioTech was founded in 2018 by Anandagopu Perumal in Thanjavur, India. Operations are focused on the pharmaceutical sector, where generic and biosimilar drugs are produced. Manufacturing activities are based in India, emphasizing cost-effective alternatives to branded pharmaceuticals. Distribution and development efforts are conducted to support healthcare accessibility in regional markets. The companys structure centers on regulatory compliance and quality standards in drug production.
Lysine BioTech's top competitors include Merck, Roivant Sciences and AbbVie.
Lysine BioTech offers CAR T Cells, Gene Therapy, Biosimilars, Vaccines, and Metabolomic Informatics.